Dr. John B. Crew, M.D.
Radiation Oncology (Radiation Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Alabama School of Medicine (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 160
Licensed in Alabama since 2013, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Medical school: University of Alabama School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Radiation Oncology Physician primary
AL license 32365 (first issued 2013; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Dch Regional Medical Center Tuscaloosa, AL
Medical groups
- Dch Healthcare Authority (17 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 160
- Services billed
- 1,517
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Ct guidance for insertion of radiation therapy fields | 636 | 45 |
| Radiation treatment management, 5 treatment sessions | 234 | 81 |
| Design and construction of complex radiation treatment device | 168 | 56 |
| Calculation of radiation therapy dose | 107 | 37 |
| Established patient office or other outpatient visit, 20-29 minutes | 75 | 56 |
| Complex radiation therapy planning | 73 | 69 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 44 | 44 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 43 | 37 |
| New patient office or other outpatient visit, 60-74 minutes | 41 | 41 |
| New patient office or other outpatient visit, 45-59 minutes | 27 | 27 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Tuscaloosa, AL | 63 |
| Ondansetron Hcl Other prescribers in Tuscaloosa, AL | 53 |
| Dexamethasone Other prescribers in Tuscaloosa, AL | 42 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Tuscaloosa, AL | 31 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Tuscaloosa, AL | 31 |
| Morphine Sulfate Er (morphine sulfate) Other prescribers in Tuscaloosa, AL | 15 |
| Bicalutamide | 12 |
| Venlafaxine Hcl Er (venlafaxine hcl) Other prescribers in Tuscaloosa, AL | 12 |
| Ssd (silver sulfadiazine) Other prescribers in Tuscaloosa, AL | 11 |
| Fluconazole Other prescribers in Tuscaloosa, AL | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 41 payments worth $837 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $136 |
|---|---|
| Novartis Pharmaceuticals Corporation | $136 |
| Merck Sharp & Dohme LLC | $77.51 |
| Stemline Therapeutics Inc. | $72.24 |
| Novocure Inc. | $65.67 |
| Blueprint Medicines Corporation | $57.25 |
| Aveo Pharmaceuticals, Inc. | $54.74 |
| Pfizer Inc. | $32.10 |
| Food and Beverage | $811 |
|---|---|
| Education | $25.70 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC Sep 16, 2025 | Education KEYTRUDA · ONCOLOGY · in-kind | $25.70 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.